Covered recipient · General Payments record
CRAIGAN T GRIFFIN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$4,970.29
- Reported across 251 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $440.04 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $171.83 | 15 |
| NEUROPACE, INC. | $79.86 | 4 |
| UCB, Inc. | $32.81 | 2 |
| ARGENX US, INC. | $31.39 | 1 |
| Lilly USA, LLC | $22.17 | 1 |
| GENZYME CORPORATION | $21.53 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.82 | 1 |
| CSL Behring | $17.36 | 1 |
| Teva Pharmaceuticals USA, Inc. | $16.04 | 1 |
| Neurocrine BioSciences, Inc. | $15.51 | 1 |
| Merz Pharmaceuticals, LLC | $13.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.08 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839340 | CMS |
| ABBVIE INC. | $6.55 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839342 | CMS |
| ABBVIE INC. | $7.50 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839344 | CMS |
| ABBVIE INC. | $9.00 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839346 | CMS |
| ABBVIE INC. | $6.82 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839348 | CMS |
| ABBVIE INC. | $10.21 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839350 | CMS |
| ABBVIE INC. | $9.67 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839352 | CMS |
| ABBVIE INC. | $7.26 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839354 | CMS |
| ABBVIE INC. | $20.91 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839356 | CMS |
| ABBVIE INC. | $11.50 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839358 | CMS |
| ABBVIE INC. | $8.71 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839360 | CMS |
| ABBVIE INC. | $16.87 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839362 | CMS |
| ABBVIE INC. | $5.56 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839364 | CMS |
| ABBVIE INC. | $34.66 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839366 | CMS |
| ABBVIE INC. | $9.53 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839368 | CMS |
| ARGENX US, INC. | $31.39 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142122893 | CMS |
| CSL Behring | $17.36 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134596879 | CMS |
| GENZYME CORPORATION | $21.53 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139693804 | CMS |
| Lilly USA, LLC | $22.17 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136133004 | CMS |
| Merz Pharmaceuticals, LLC | $13.72 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137948010 | CMS |
| Neurocrine Biosciences, Inc. | $15.51 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150873528 | CMS |
| NEUROPACE, INC. | $22.75 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153273358 | CMS |
| NEUROPACE, INC. | $25.68 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153273402 | CMS |
| NEUROPACE, INC. | $16.62 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153273406 | CMS |
| NEUROPACE, INC. | $14.81 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153273364 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.82 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137563404 | CMS |
| Teva Pharmaceuticals USA, Inc. | $16.04 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151601484 | CMS |
| UCB, Inc. | $19.63 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143061715 | CMS |
| UCB, Inc. | $13.18 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143061717 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.